Do you have a higher threshold regarding when to hold bevacizumab for proteinuria in patients who had known baseline proteinuria from diabetic nephropathy?  

This is an interesting question. It’s not uncommon to have patients with cancer who have other underlying conditions that may lead to proteinuria. I don’t have a higher or lower threshold to recommend holding VEGF inhibitors, but in all patients who are on them who develop proteinuria, t...

I agree with Dr. @Anushree Shirali. Each patient has their associated comorbidities and their response to bevacizumab and availability of other therapeutic options do factor into the decision-making regarding tolerable levels of proteinuria. The proteinuria trend also factors into decision-making. I...